MRC Clinical Trials Unit at UCL
90 High Holborn
2nd Floor
London
WC1V 6LJ
Email: mrcctu.kdcaap@ucl.ac.uk
UCL is the data controller for this study. A data controller collects and processes personal information. It also determines why and how the data is processed.
In KD-CAAP data will be collected from sites and generated from samples to answer the study question - whether giving steroids in addition to IVIG and Aspirin to children with Kawasaki Disease reduces heart complications.
Information on how University College London uses personal information can be found in the privacy notices on their website.
If you have further questions regarding the data collection in the KD-CAAP trial contact the KD-CAAP Coordinating Centre.
KD-CAAP
Coordinating Centre
MRC Clinical Trials Unit at UCL
90 High Holborn
2nd Floor
London
WC1V 6LJ
Email: mrcctu.kdcaap@ucl.ac.uk